Strs Ohio Beyond Spring Inc. Transaction History

Strs Ohio

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$4.02 - $16.84 $20,099 - $84,200	-5,000 Closed	0 $0
Q3 2021 Oct 22, 2021	BUY	$9.26 - $31.31 $46,300 - $156,550	5,000 New	5,000 $78,000
Q2 2021 Jul 26, 2021	SELL	$9.37 - $12.12 $166,786 - $215,736	-17,800 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$10.21 - $17.31 $181,738 - $308,118	17,800 New	17,800 $217,000
Q3 2019 Oct 21, 2019	SELL	$15.33 - $23.85 $44,457 - $69,165	-2,900 Closed	0 $0
Q2 2019 Jul 25, 2019	BUY	$13.36 - $23.7 $38,744 - $68,730	2,900 New	2,900 $68,000

5.55M

26K

2.4K

Ticker BYSI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,928,900
Market Cap $66.6M
Description
BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

Stay updated on Strs Ohio with notifications on news.